Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ACRS | Aclaris Therapeutics, Inc. | Powala Christopher | Chief Reg & Develop Officer | Feb 01, 2019 | Option Exercise | $6.96 | 1,114 | 7,753 | 141,729 | Feb 05, 2019, 06:33 PM | |
ACRS | Aclaris Therapeutics, Inc. | Powala Christopher | Chief Reg & Develop Officer | Dec 18, 2018 | Option Exercise | $6.30 | 446 | 2,810 | 139,443 | Dec 21, 2018, 07:29 AM | |
ACRS | Aclaris Therapeutics, Inc. | Powala Christopher | Chief Reg & Develop Officer | Dec 15, 2018 | Option Exercise | $7.31 | 357 | 2,610 | 138,264 | Dec 18, 2018, 08:51 PM | |
ACRS | Aclaris Therapeutics, Inc. | Powala Christopher | Chief Reg & Develop Officer | May 07, 2018 | Option Exercise | $18.10 | 1,480 | 26,788 | 137,321 | May 09, 2018, 04:19 PM | |
ACRS | Aclaris Therapeutics, Inc. | Powala Christopher | Chief Operating Officer | Dec 15, 2017 | Option Exercise | $24.23 | 395 | 9,571 | 132,470 | Dec 21, 2017, 04:57 PM | |
ACRS | Aclaris Therapeutics, Inc. | Powala Christopher | Chief Operating Officer | Dec 18, 2017 | Option Exercise | $24.12 | 494 | 11,915 | 133,601 | Dec 21, 2017, 04:57 PM | |
ACRS | Aclaris Therapeutics, Inc. | Powala Christopher | Chief Operating Officer | Dec 18, 2016 | Option Exercise | $31.25 | 494 | 15,438 | 131,565 | Dec 20, 2016, 06:51 PM |